Treatment of Acute Lymphoblastic Leukemia in Children
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to reduce the side-effects from anti-leukemia therapy. The
therapy in this study is based upon treatment information learned from prior clinical
research programs as well as from laboratory research.
Phase:
Phase 3
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Boston Children's Hospital Boston Children’s Hospital Columbia University Laval University Maine Children's Cancer Program McMaster University Ochsner Health System San Jorge Children's Hospital (Puerto Rico) St. Justine's Hospital Tulane University School of Medicine University of Rochester